Showing results (1271-1280 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|June 4, 2024
Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary updateRebecca Romanò, Francesca De Felice, Andrea Ferri, et al.Expert Review of Anticancer Therapy|June 12, 2024
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancerRenata Pacholczak-Madej, Michele Bartoletti, Lucia Musacchio, et al.Expert Review of Anticancer Therapy|May 18, 2024
Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysisMeng-Fei Dai, Xin Wang, Wen-Xiu Xin, et al.Expert Review of Anticancer Therapy|September 29, 2023
The role of immune checkpoint inhibition in triple negative breast cancerKidist Tarekegn, Merve Keskinkilic, Tyler J Kristoff, et al.Expert Review of Anticancer Therapy|September 29, 2023
Treatment of advanced ALK-rearranged NSCLC following second-generation ALK-TKI failureAkito Fukuda, Tatsuya YoshidaExpert Review of Anticancer Therapy|September 25, 2023
Progress in immune checkpoint inhibition in early-stage triple-negative breast cancerAhmed Mohamed, Megan Kruse, Jennifer TranExpert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.Expert Review of Anticancer Therapy|June 21, 2023
Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapyHao Yao, Lei Cheng, Dan Chen, et al.Expert Review of Anticancer Therapy|January 26, 2019
Targeting angiogenesis in metastatic renal cell carcinomaCostanza Canino, Lorenzo Perrone, Eugenia Bosco, et al.Expert Review of Anticancer Therapy|January 26, 2019
Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitorsAmro Elshoury, Amanda Przespolewski, Jeffrey Baron, et al.Pageof 310